The FDA gives a hint of hope for the long-delayed Eli Lilly/Daiichi Sankyo drug prasugrel. Burrow deep inside this 357-page FDA document just posted online, and you’ll find this jargony but …
Today’s Top Three in Pharma 012809
Astellas makes a big to acquire CV Therapeutics. Japan's Astellas Pharma is offering a billion dollars in cash for CV Therapeutics. The bid comes in at $16 a share, a whopping 41 percent premium over …
Today’s Top Three in Pharma 011509
Wasn't able to get to a "Top Three" yesterday, as I was attending a (VERY interesting) real-time communications conference in NYC. Blog post coming on that. Meanwhile... Pfizer, Pfizer, Pfizer. 800 …
Pharma News this week (and last)
Roche's MabThera can help extend CLL patients' lives. Meanwhile, surprisingly good results for AZ's lung cancer drug Iressa. But, disappointment for an experimental lung cancer drug being developed by …
Pharma News this week
Some surprises in the new diabetes guidelines issue by the American Diabetes Association and European Association for the Study of Diabetes...more Speaking of diabetes - we're paying a lot more over …